References
- M. Ashford, J. Fell.(1994). Targeting drugs to the colon: Delivery systems for oral administration J. Target. 2:241–258.
- A. Banga, Y. Chien.(1988). Systemic delivery of therapeutic peptides and proteins Int. J. Pharm. 48:15–50.
- R. Caprilli, A. Andeoli, L. Capurso, G. Corrao, G. D'Albasio, A. Gioieni, G. Lanfranchi, I. Paladini, F. Pallone, V. Ponti, G. Rigo, F. Rossini, G. Sturniolo, F. Tonelli, D. Valpiani(1994). Oral mesalazin (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of Crohn's disease Alim. Pharm. Ther. 8:35–43.
- A. Clark, R. Peter, V. Cheryl.(1981). Fluorescein pharmacokinetics in the beagle J. Pharm. Pharmacol. 33:39P
- J. Dressman.(1986). Comparison of canine and human gastrointestinal physiology Pharm. Res. 3:123–131.
- R. Ishino, Y. Hirakawa, K. Noda.(1992). Design and preparation of pulsatile release tablet as a new oral drug delivery system Chem. Pharm. Bull. 40:3036–3041.
- T. Itoh, T. Higuchi, C. Gardner.(1986). Effect of particle size and food on gastric residence time of non‐disintegrating solids in beagle dogs J. Pharm. Pharmacol. 38:801–806.
- M. Kennedy, P. Chinwah, D. Wade.(1979). A pharmacological method of measuring mouth caecal transit time in man Br. J. Clin. Pharmac. 8:372–373.
- A. Kiriyama, M. Sugahara, Y. Yoshikawa, Y. Kiso, K. Takada.(1995). Bioavailability of oral dosage forms of new HIV‐1 protease inhibitor, KNI‐272, in beagle dogs Biopharm. Drug Dispos.
- J. Kjaergaard, K. Dideriksen, T. Andersen.(1983). Some aspects of the phormacokinetics of fluorescein in normal and in diabetic subjects Int. J. Microcirc. 2:191–197.
- M. Kraeling, W. Ritschel.(1992). Development of a colonic release capsule dosage form and the absorption of insulin Meth. Find. Exptl. Clin. Pharmacol. 14:199–209.
- J. Kopecek.(1977). Reactive copolymers of N‐(2‐hydroxypropyl)‐methacrylamide with N‐methacryloylated derivatives of L‐leucine and L‐phenylalanine I. Preparation, characterization and reaction with diamines Macromol, Chem. 178:2169
- H. Mizuta, Y. Kawazoe, Y. Haga, K. Ogawa, T. Yokobe.(1989). Determination of small intestinal transit time in beagle dogs using salicylazosulfapyridine Yakugaku zasshi. 109:760–765.
- K. Niwa, T. Takaya, T. Morimoto, K. Takada.(1995). Preparation and evaluation of a time‐controlled release capsule made of ethylcellulose for colon delivery of drugs J. Target. 3:83–89.
- R. Pellicciari, A. Aburbeh, B. Natalini, M. Marinozzi.(1993). Brush‐border‐enzyme‐mediated intestine‐specific drug delivery. Amino acid prodrugs of 5‐aminosalicylic acid J. Med. Chem. 36:4201–207.
- W. Ritschel.(1991). Targeting in the gastrointestinal tract: New approaches Meth. Find. Exptl. Clin. Pharmacol. 13:313–336.
- P. Smith, D. Wall, C. Gochoco, G. Wilson.(1992). Oral absorption of peptides and proteins Adv. Drug Deliv. Rev. 8:253–290.
- K. Steed, G. Hooper, P. Ventura, R. Musa, I. Wilding.(1994). The in vivo behaviour of a colonic delivery system: a pilot study in man Int. J. Pharm. 112:199–206.
- T. Takaya, C. Ikeda, N. Imagawa, K. Niwa, K. Takada.(1995). Development of a colon delivery capsule and the pharmacological activity of recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) in beagle dogs J. Pharm. Pharmacol. 47:474–478.
- T. Takaya, K. Sawada, H. Suzuki, A. Funaoka, K. Matsuda, K. Takada.(1995). Usefulness of a colon delivery capsule for oral administration of 5‐Aminosalicylic acid in beagle dogs In 115 The Pharmaceutical Society of Japan. Sendai. 4:68
- I. Wilding, S. Davis, D. O'Hagan.(1994). Targeting of drug and vaccines to the gut Pharmac. Ther. 62:97–124.
- T. Yamaguchi, K. Sasaki, Y. Kurosaki, T. Nakayama, T. Kimura.(1994). Biopharmaceutical evaluation of salicylazo‐sulfanilic acid as a novel colon‐targeted prodrug of 5‐aminosalicylic acid J. Target. 2:123–131.
- X. Zhou.(1994). Overcoming enzymatic and absorption barriers to nonparenterally administered protein and peptide drugs J. Cont. Rele. 29:239–252.
- N. Aoyagi.(1989). Iyakuyin no baioabeilabilitei to seibutsugakutekidoutouseishiken (in Japanese)99–124.
- J. Dressman.(1989). Drug delivery to the gastrointestinal tract195–228.
- D. Friend.(1992). Oral Colon‐Specific Drug Delivery
- C. Wilson.C. Washington.N. Washington.(1989). Physiological pharmaceutics: Biological barriers to drug absorption47–70.